1.2100
+0.0150
+(1.26%)
At close: 9:10:11 AM GMT+2
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
159,387
293,478
305,441
414,166
Total Liabilities Net Minority Interest
42,833
49,162
39,675
28,207
Total Equity Gross Minority Interest
116,554
244,316
265,766
385,959
Total Capitalization
130,430
260,839
275,857
377,651
Common Stock Equity
116,297
242,962
260,740
376,908
Capital Lease Obligations
1,209
1,265
224
--
Net Tangible Assets
112,720
241,190
260,740
376,908
Working Capital
55,174
165,472
267,248
354,147
Invested Capital
139,794
260,839
275,857
377,651
Tangible Book Value
112,720
241,190
260,740
376,908
Total Debt
24,706
19,142
15,341
743
Net Debt
5,992
--
--
--
Share Issued
193,992.8730
166,026.3960
165,935.9140
160,677.0010
Ordinary Shares Number
193,992.8730
166,026.3960
165,935.9140
160,677.0010
12/31/2021 - 11/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIO.DE Biotest Aktiengesellschaft
42.40
0.00%
7V0.DE Darwin AG
27.00
-0.74%
88Q.DE 4basebio PLC
12.90
-1.53%
AYJ.DE Valneva SE
3.0260
+1.89%
NVV1.DE Novavax, Inc.
7.85
-0.53%
BIO3.DE Biotest Aktiengesellschaft
30.20
+0.67%
VX1.DE Vertex Pharmaceuticals Incorporated
430.20
-1.19%
HPHA.DE Heidelberg Pharma AG
2.6100
+0.38%
NP5.DE Newron Pharmaceuticals S.p.A.
7.00
+1.16%
BBZA.DE BB Biotech AG
28.65
-1.04%